I simply believe in the story of the company.
I also like the journey so far. I think they are keeping a tight ship and I can not fault them with the management of their budgets over the past 2 years.
I also like the recent additions to the senior management team. This is the clearest signal of their intentions to find an appropriate big pharma player to acquire BOT.
They have several interesting products that are close to my interests (I'm a pharmacist). I believe some of these products will be commercialised (whether under BOT or another company.... To be honest, BOT does not have the competencies to commercialise the product as well as the big pharma. A company like Pfizer or Merck would do a far better job (and they have the expertise, networks, resources, people and know how) in successfully commercialising the product.
BOT - Anything but charting, page-282
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $581.5M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 31.5¢ | $1.940M | 6.061M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 470483 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 33000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |